LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT

Clinical trials for LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT explained in plain language.

Never miss a new study

Get alerted when new LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT trials appear

Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New combo aims to hold cancer at bay, paving way for potentially curative CAR-T

Disease control Recruiting now

This study is testing a two-drug combination (golcadomide and rituximab) as a 'bridge' treatment for adults with aggressive B-cell lymphoma that has returned or not responded to prior therapy. The goal is to control the cancer and improve patients' health so they can proceed to a…

Matched conditions: LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT

Get alerted when new LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT trials appear

New combo aims to hold cancer at bay, paving way for potentially curative CAR-T